Found 4 hits for monomerid = 50374624 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50374624
(CHEMBL410892)Show SMILES CN(C)CCOc1ccc(Nc2ncc3c(n2)n2c4ccccc4nc2n(-c2c(C)cccc2C)c3=O)cc1 |(11.02,-18.02,;12.35,-18.79,;13.68,-18.02,;12.35,-20.33,;13.68,-21.1,;15.02,-20.33,;16.35,-21.1,;17.69,-20.33,;19.02,-21.11,;19.01,-22.65,;20.34,-23.42,;21.67,-22.65,;21.68,-21.11,;23,-20.34,;24.34,-21.1,;24.34,-22.65,;23.01,-23.42,;25.68,-23.42,;26,-24.92,;25.09,-26.15,;25.71,-27.56,;27.24,-27.72,;28.14,-26.49,;27.52,-25.09,;28.16,-23.68,;27.01,-22.65,;27.02,-21.1,;28.35,-20.33,;28.35,-18.8,;27.01,-18.03,;29.68,-18.03,;31.02,-18.8,;31.01,-20.34,;29.68,-21.11,;29.67,-22.65,;25.68,-20.32,;25.68,-18.78,;17.69,-23.42,;16.35,-22.65,)| Show InChI InChI=1S/C30H29N7O2/c1-19-8-7-9-20(2)26(19)37-28(38)23-18-31-29(32-21-12-14-22(15-13-21)39-17-16-35(3)4)34-27(23)36-25-11-6-5-10-24(25)33-30(36)37/h5-15,18H,16-17H2,1-4H3,(H,31,32,34) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of Lck by HTRF assay |
J Med Chem 51: 1637-48 (2008)
Article DOI: 10.1021/jm701095m BindingDB Entry DOI: 10.7270/Q23B6114 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50374624
(CHEMBL410892)Show SMILES CN(C)CCOc1ccc(Nc2ncc3c(n2)n2c4ccccc4nc2n(-c2c(C)cccc2C)c3=O)cc1 |(11.02,-18.02,;12.35,-18.79,;13.68,-18.02,;12.35,-20.33,;13.68,-21.1,;15.02,-20.33,;16.35,-21.1,;17.69,-20.33,;19.02,-21.11,;19.01,-22.65,;20.34,-23.42,;21.67,-22.65,;21.68,-21.11,;23,-20.34,;24.34,-21.1,;24.34,-22.65,;23.01,-23.42,;25.68,-23.42,;26,-24.92,;25.09,-26.15,;25.71,-27.56,;27.24,-27.72,;28.14,-26.49,;27.52,-25.09,;28.16,-23.68,;27.01,-22.65,;27.02,-21.1,;28.35,-20.33,;28.35,-18.8,;27.01,-18.03,;29.68,-18.03,;31.02,-18.8,;31.01,-20.34,;29.68,-21.11,;29.67,-22.65,;25.68,-20.32,;25.68,-18.78,;17.69,-23.42,;16.35,-22.65,)| Show InChI InChI=1S/C30H29N7O2/c1-19-8-7-9-20(2)26(19)37-28(38)23-18-31-29(32-21-12-14-22(15-13-21)39-17-16-35(3)4)34-27(23)36-25-11-6-5-10-24(25)33-30(36)37/h5-15,18H,16-17H2,1-4H3,(H,31,32,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of KDR by HTRF assay |
J Med Chem 51: 1637-48 (2008)
Article DOI: 10.1021/jm701095m BindingDB Entry DOI: 10.7270/Q23B6114 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50374624
(CHEMBL410892)Show SMILES CN(C)CCOc1ccc(Nc2ncc3c(n2)n2c4ccccc4nc2n(-c2c(C)cccc2C)c3=O)cc1 |(11.02,-18.02,;12.35,-18.79,;13.68,-18.02,;12.35,-20.33,;13.68,-21.1,;15.02,-20.33,;16.35,-21.1,;17.69,-20.33,;19.02,-21.11,;19.01,-22.65,;20.34,-23.42,;21.67,-22.65,;21.68,-21.11,;23,-20.34,;24.34,-21.1,;24.34,-22.65,;23.01,-23.42,;25.68,-23.42,;26,-24.92,;25.09,-26.15,;25.71,-27.56,;27.24,-27.72,;28.14,-26.49,;27.52,-25.09,;28.16,-23.68,;27.01,-22.65,;27.02,-21.1,;28.35,-20.33,;28.35,-18.8,;27.01,-18.03,;29.68,-18.03,;31.02,-18.8,;31.01,-20.34,;29.68,-21.11,;29.67,-22.65,;25.68,-20.32,;25.68,-18.78,;17.69,-23.42,;16.35,-22.65,)| Show InChI InChI=1S/C30H29N7O2/c1-19-8-7-9-20(2)26(19)37-28(38)23-18-31-29(32-21-12-14-22(15-13-21)39-17-16-35(3)4)34-27(23)36-25-11-6-5-10-24(25)33-30(36)37/h5-15,18H,16-17H2,1-4H3,(H,31,32,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of p38-alpha by HTRF assay |
J Med Chem 51: 1637-48 (2008)
Article DOI: 10.1021/jm701095m BindingDB Entry DOI: 10.7270/Q23B6114 |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50374624
(CHEMBL410892)Show SMILES CN(C)CCOc1ccc(Nc2ncc3c(n2)n2c4ccccc4nc2n(-c2c(C)cccc2C)c3=O)cc1 |(11.02,-18.02,;12.35,-18.79,;13.68,-18.02,;12.35,-20.33,;13.68,-21.1,;15.02,-20.33,;16.35,-21.1,;17.69,-20.33,;19.02,-21.11,;19.01,-22.65,;20.34,-23.42,;21.67,-22.65,;21.68,-21.11,;23,-20.34,;24.34,-21.1,;24.34,-22.65,;23.01,-23.42,;25.68,-23.42,;26,-24.92,;25.09,-26.15,;25.71,-27.56,;27.24,-27.72,;28.14,-26.49,;27.52,-25.09,;28.16,-23.68,;27.01,-22.65,;27.02,-21.1,;28.35,-20.33,;28.35,-18.8,;27.01,-18.03,;29.68,-18.03,;31.02,-18.8,;31.01,-20.34,;29.68,-21.11,;29.67,-22.65,;25.68,-20.32,;25.68,-18.78,;17.69,-23.42,;16.35,-22.65,)| Show InChI InChI=1S/C30H29N7O2/c1-19-8-7-9-20(2)26(19)37-28(38)23-18-31-29(32-21-12-14-22(15-13-21)39-17-16-35(3)4)34-27(23)36-25-11-6-5-10-24(25)33-30(36)37/h5-15,18H,16-17H2,1-4H3,(H,31,32,34) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 440 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of Src by HTRF assay |
J Med Chem 51: 1637-48 (2008)
Article DOI: 10.1021/jm701095m BindingDB Entry DOI: 10.7270/Q23B6114 |
More data for this Ligand-Target Pair | |